Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
复制标题
R,S-(内消旋)-α,α-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯在狗离体和小鼠体内的抗血小板作用。
DOI:
10.1016/s0306-3623(96)00272-8
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Gollamudi,R
中科院分区:
文献类型:
--
作者:
Han,G;Bannerman,D;Handa,RK;Dillingham,EO;Lawrence,WH;Gollamudi,R
1. The nipecotamide alpha, alpha'-bis [3-(N, N-diethylcarbamoyl) piperidino]-p-xylene (A-1) is a platelet aggregation inhibitor. The meso diastereomer A-1c is superior in potency and duration to the synthetic diastereomeric mixture consisting of the R, R-, S, S-, and R, S-(meso) isomers in inhibiting collagen-induced platelet aggregation ex vivo in the dog. 2. A-1c also is more potent and longer acting than A-1 in protecting mice from collagen+ epinephrine-induced thromboembolic death. 3. The mechanism of antiplatelet action of this compound appears to be related to its ability to prevent agonist-induced inhibition of platelet cyclic adenosine monophosphate (cAMP) levels.